Boston, MA -- (SBWIRE) -- 10/22/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Cellceutix Corp (OTCMKTS:CTIX), Itau Unibanco Holding SA (ADR) (NYSE:ITUB), Cirrus Logic, Inc. (NASDAQ:CRUS), Galena Biopharma Inc (NASDAQ:GALE).
Cellceutix Corp (OTCMKTS:CTIX) opened its shares at the price of $1.74for the day. Its closing price was $1.82after gaining7.06% for the day. The company traded with the total volume of 229,487 shares, while its average trading volume remained 312,647 shares. The beta of CTIX stands at0.71.
Will CTIX Continue To Move Higher? Find Out Here
Cellceutix Corporation, a development stage biopharmaceutical company, engages in the discovery and development of small molecule drugs to treat diseases primarily in the areas of cancer and inflammatory disease.
Itau Unibanco Holding SA (ADR) (NYSE:ITUB) percentage change plunged -0.90% to close at $15.37 with the total traded volume of 13.18 million shares, and average volume of 11.31 million. The 52 week range of the stock remained $11.38 - $17.34, while its day lowest price was $15.23 and it hit its day highest price at $15.55.
Will ITUB Get Buyers Even After The Recent Rally? Find Out Here
Itaú Unibanco Holding S.A. provides various financial products and services in Brazil and internationally.
Cirrus Logic, Inc. (NASDAQ:CRUS) started its trading session with the price of $24.94 and closed at $25.73 by scoring 4.17%. CRUS’s stocks traded with total volume of 3.93 million shares, while the average trading volume remained 2.55 million shares. The beta of CRUS stands at 0.48. Day range of the stock was $24.75 -$25.91.
Will CRUS Continue To Move Higher? Find Out Here
Cirrus Logic, Inc., a fabless semiconductor company, develops analog and mixed-signal integrated circuits (ICs) for a range of consumer and industrial markets.
Galena Biopharma Inc (NASDAQ:GALE) ended its day with the loss of -0.45% and closed at the price of $2.21 after opening at $2.27. Stock traded during its last trading session with the total volume of 1.70 million shares, as compared to its average volume of 3.74 million shares.
Will GALE Get Buyers Even After The Recent Rally? Find Out Here
Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care.
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)